Agilon Health, Inc.

NYSE:AGL

Medical - Care Facilities

Healthcare
$90.53 +2.16%

+$2.26 today

Market cap
$1.52B
Beta
3.04
P/E (TTM)
-4.8
EPS (TTM)
-$22.50
52W Low $7.48High $118.25

Volume 0.79M

Average 0.41M

AGL Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Agilon Health, Inc.NYSE: AGL

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 16.66M shares rose 0.9% year over year, in line with the +0.7% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.5% from the prior quarter. Over 3 fiscal years it compounded at +0.5% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +0.9% holds above the trailing-twelve-month pace of +0.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
16.66M+0.5% QoQ
Last fiscal yearDec 2025
16.56M+0.7% YoY
LTMMar 2026
16.59M+0.7% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.9%——
1 year+0.7%——
3-year CAGR+0.5%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
16.56M USD
Year-over-year change
+0.7%
4-year CAGR
+2.6%

Weighted Avg Shares (Diluted) vs competitors

How AGL compares with its peers on the latest reported figures

  • AGL's LTM Mar 2026 weighted avg shares (diluted) of 16.59M shares is the 9th highest of the 10 companies compared; the peer median is 68.62M shares.
  • Its year-over-year change of +0.7% is the 6th highest of 10, against a peer median of +3.6%.
  • Over three fiscal years its annual growth of +0.5% compares with a peer median of +14.1%.
AGL Competitors Peer median
Weighted Avg Shares (Diluted) for AGL and competitors
Company Period LTM YoY 3-year CAGR
ANNXAnnexon, Inc.LTM Mar 2026161.69M +14.3%+41.6%
DHDefinitive Healthcare Corp.LTM Mar 2026104.66M -9.4%+1.8%
DBVTDBV Technologies S.A.LTM Mar 202688.66M -7.8%+3.7%
LRMRLarimar Therapeutics, Inc.LTM Mar 202678.18M +22.5%+41.5%
SOPHSOPHiA GENETICS S.A.LTM Mar 202668.62M +3.6%+1.8%
ENGNenGene Holdings Inc.LTM Apr 202659.85M +25.2%+47.9%
SLPSimulations Plus, Inc.LTM Feb 202620.18M -0.4%-1.1%
MCTACharming Medical Limited Class A Ordinary SharesFY202416.94M +0.0%—
AGLAgilon Health, Inc.LTM Mar 202616.59M +0.7%+0.5%
NAKANakamoto Inc.LTM Mar 202611.36M +89.0%+24.5%
Peer median (excluding AGL) 68.62M+3.6%+14.1%

Competitors are the stored peer set for AGL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.52B2.39B4.32B6.06B5.93B
Cost of Revenue1.46B2.28B4.25B6.06B6.12B
Gross Profit65.74M111.36M69.67M4.84M(188.61M)
Gross Margin4.3%4.7%1.6%0.1%-3.2%
Research & Development00000
Selling, General & Admin427.5M207.79M285.76M268.91M238.54M
Operating Expenses437.99M216.74M301.8M296.97M232.46M
Depreciation & Amortization14.67M13.77M20.16M24.46M28.59M
EBITDA(362.16M)(72.41M)(167.64M)(218.19M)(368.86M)
EBITDA Margin-23.8%-3.0%-3.9%-3.6%-6.2%
Operating Income(372.24M)(105.38M)(232.13M)(292.13M)(421.08M)
Operating Margin-24.5%-4.4%-5.4%-4.8%-7.1%
Interest Income00000
Interest Expense6.15M4.48M6.66M6.18M6.64M
Other Income / Expenses(10.73M)14.71M37.67M43.3M16.98M
Income Before Tax(382.98M)(90.67M)(194.46M)(248.83M)(404.1M)
Pre-Tax Margin-25.2%-3.8%-4.5%-4.1%-6.8%
Income Tax Expense886K1.64M791K1.45M1.25M
Net Income(406.49M)(106.55M)(262.6M)(260.15M)(405.35M)
Net Margin-26.7%-4.5%-6.1%-4.3%-6.8%
EPS (Basic)(27.25)(6.50)(16.00)(15.75)(24.50)
EPS (Diluted)(27.25)(6.50)(16.00)(15.75)(24.50)
Weighted Avg Shares14.92M16.33M16.36M16.44M16.56M
Weighted Avg Shares (Diluted)14.92M16.33M16.36M16.44M16.56M

Agilon Health, Inc.

NYSE:AGL

Intrinsic Alpha fair value

Locked

Current Price

$90.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.